Skip to main content
. 2009 Mar 25;58(11):1819–1830. doi: 10.1007/s00262-009-0693-8

Table 5.

Intracytoplasmic cytokine synthesis by cancer antigen peptide-specific T cell lines generated from PBMC and stimulated with the relevant GCAA peptide

Patients Proportion (%) of peptide-reactive T cell blasts expressing cytokines
CD4+ IFN-γ+ CD4+IL-4+ CD8+ IFN-γ+ CD8+IL-4+
 02.CC 11.2 0.11 15.1 0.19
 03.CA 12.1 <0.1 12.8 <0.1
 04.FM 6.2 <0.1 10.3 <0.1
 05.PF 10.0 0.10 11.9 0.18
 06.CAn 11.9 <0.1 16.3 0.20
 08.DN 10.9 0.20 13.9 0.10
 09.BG 7.8 <0.1 10.0 <0.1
 10.BA 10.3 <0.1 13.0 <0.1
 11.BS 8.1 <0.1 9.1 <0.1
 12.BG 8.9 <0.1 10.8 <0.1
 13.MS 11.9 0.10 12.7 0.17
 14.AC 7.0 <0.1 10.1 <0.1
 17.MM 7.2 <0.1 10.3 0.39
 18.SB 11.8 0.19 15.0 <0.1
 19.AB 15.1 0.18 16.2 <0.1
 20.BF 10.1 <0.1 11.4 <0.1

Intracytoplasmic IL-4 and IFN-γ positive T cell blasts of PBMC-derived peptide-specific T cell lines. GCAA peptide specific T cell lines were obtained from 16 of 20 patients with gastric adenocarcinoma. T cell blasts were stimulated with peptides (10 μg/ml) and intracellular cytokine synthesis was evaluated by cytofluorometric analysis. Results represent mean proportions of cytokine-positive cells over the background values obtained with isotype-control monoclonal antibodies